Company News

J&J and SciBase Collaborate on Screening Tool to Detect Skin Barrier Dysfunction in Infants

Using AI to predict the development of atopic dermatitis/eczema.

Author Image

By: Christine Esposito

Editor-in-Chief

SciBase Holding AB, a Stockholm-based developer of augmented intelligence (AI)-based solutions for skin disorders, announced today that it has signed an agreement with Johnson & Johnson Consumer Inc. to collaborate on the development of an AI-based screening tool to predict the development of atopic dermatitis in infants. The goal of the collaboration is to develop and validate an AI-based solution that detects skin barrier dysfunction and may be able to predict an infant's risk of ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters